scholarly journals Identical or similar brand names used in different countries for medications with different active ingredients: a descriptive analysis

2020 ◽  
Vol 29 (12) ◽  
pp. 988-991
Author(s):  
Lubna Merchant ◽  
Randall Lutter ◽  
Sherry Chang
Keyword(s):  
Medication Errors ◽  
Descriptive Analysis ◽  
Brand Names ◽  
Uppsala Monitoring Centre ◽  
Brand Name ◽  
Active Ingredients ◽  
Monitoring Centre ◽  
Regulatory Authorities ◽  
Wrong Drug ◽  
The Us

ObjectiveTo identify US drug brand (proprietary) names that are identical or similar to drug brand names used in other countries containing different active ingredients and name confusion medication errors associated with these drugs.MethodsWe compared a list of brand names approved by the US Food and Drug Administration from 2006 through 2018 with a list of brand names from other countries generated by Uppsala Monitoring Centre using the WHODrug Dictionary. We evaluated drug name pairs that were identical or highly similar and had different active ingredients and searched for name confusion medication errors with these drugs.ResultsA total of 27 US brand names were found to be identical to 38 drug brand names in other countries with different active ingredients. A total of 74 US drug brand names were highly similar to 93 brand names in other countries for drugs containing different active ingredients. We identified name confusion medication errors for one similar name pair.ConclusionsUS drug brand names that are identical to or highly similar to brand names in other countries may cause confusion that can lead to medication errors such as wrong drug errors and wrong drug information being consulted. Manufacturers should consider this risk prior to submitting proposed brand names to regulatory authorities. Regulatory authorities may consider incorporating this check in their brand name reviews and work with manufacturers to eliminate the use of the same or similar brand names for products with different ingredients. Consumers filling prescriptions at foreign pharmacies should also be aware of potential name confusion.

scholarly journals Confusing brand names - algorithms to assess the confusability to dispensers and risk to patients

2015 ◽  
Vol 1 (1) ◽  
pp. 52
Author(s):  
Padmanabh Rataboli ◽  
Akshay Khandeparkar ◽  
Suvidha Khandolkar ◽  
Lokesh Chawla
Keyword(s):  
High Risk ◽  
Medical Practice ◽  
Medical Errors ◽  
Potential Risk ◽  
Medical Profession ◽  
Brand Names ◽  
Brand Name ◽  
Wrong Drug ◽  
Drug Names ◽  
The Right

<p class="abstract"><strong>Background:</strong> Brand name prescribing has been as integral part of medical practice. Confusing brand names have become a nightmare of medical profession and many are strikingly identical, similar looking (orthographic), or similar sounding (phonological). Such similarities have led to medical errors due to wrong drug being prescribed or dispensed. We have made an attempt to form algorithms to assess the confusability to dispensers or doctors and, to determine the risk to the patients by considering various parameters in the brand names.  </p><p class="abstract"><strong>Methods:</strong> Two separate algorithms are prepared with positive and negative markings to assess the confusability and the risk. The scoring system appropriately suggests the confusability of the brand names, as well as the risk posed to the patients if dispensed wrongly. Considering the confusion and the potential risk to the consumers, it is essential that the concerned authorities adopt this algorithm to determine the confusability vis-a-vis safety before they accept a new brand name. Similar brand names should be analysed and the score determined to approve or refuse the new name for the brands.</p><p class="abstract"><strong>Results:</strong> Analysing numerous examples of confusing brand names, it is proposed that an overall combined score of more than 22 (confusability plus risk together) suggests that the two names are highly confusing and pose a high risk to the patients if wrongly prescribed or dispensed. An overall score of 8 or less suggests that the drug names together are neither confusing nor risky. A combined score in between suggests that the drugs analysed are confusing but may or may not pose any risk to the patient.</p><p class="abstract"><strong>Conclusions:</strong> In conclusion, look-alike and sound-alike brand names of various drugs are here to stay. As consumer, one should find out what drug you are taking and what it’s for, and whether the right brand has been dispensed. As a doctor you should write clearly and be thoroughly familiar with the similar brands before you prescribe to prevent any “written” error. As pharmacist, one should not hesitate to phone the physician to verify the brand and its contents if the name is “confusing” with another brand. </p><p><strong>Keywords: </strong>Confusing brand names, Algorithms, Confusability, Risk</p>

scholarly journals Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health

2021 ◽  
Vol 14 (10) ◽  
pp. 965
Author(s):  
Vidyasagar Naik Bukke ◽  
Moola Archana ◽  
Rosanna Villani ◽  
Gaetano Serviddio ◽  
Tommaso Cassano
Keyword(s):  
Synthetic Cannabinoids ◽  
Cardiovascular Effects ◽  
Brand Names ◽  
Structural Modifications ◽  
Monitoring Centre ◽  
Toxicological Effects ◽  
Adverse Health Effects ◽  
The Us ◽  
Us Government ◽  
First Time

Synthetic Cannabinoids (CBs) are a novel class of psychoactive substances that have rapidly evolved around the world with the addition of diverse structural modifications to existing molecules which produce new structural analogues that can be associated with serious adverse health effects. Synthetic CBs represent the largest class of drugs detected by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with a total of 207 substances identified from 2008 to October 2020, and 9 compounds being reported for the first time. Synthetic CBs are sprayed on natural harmless herbs with an aim to mimic the euphoric effect of Cannabis. They are sold under different brand names including Black mamba, spice, K2, Bombay Blue, etc. As these synthetic CBs act as full agonists at the CB receptors, they are much more potent than natural Cannabis and have been increasingly associated with acute to chronic intoxications and death. Due to their potential toxicity and abuse, the US government has listed some synthetic CBs under schedule 1 classification. The present review aims to provide a focused overview of the literature concerning the development of synthetic CBs, their abuse, and potential toxicological effects including renal toxicity, respiratory depression, hyperemesis syndrome, cardiovascular effects, and a range of effects on brain function.

EXPRESS: Is Nestlé a Lady? The Feminine Brand Name Advantage

2021 ◽  
pp. 002224292199306
Author(s):  
Ruth Pogacar ◽  
Justin Angle ◽  
Tina M. Lowrey ◽  
L. J. Shrum ◽  
Frank R. Kardes
Keyword(s):  
Boundary Conditions ◽  
Brand Names ◽  
Brand Name ◽  
Brand Performance ◽  
The Feminine ◽  
And Performance ◽  
Typical User

A brand name’s linguistic characteristics convey brand qualities independent of the name’s denotative meaning. For instance, name length, sounds, and stress can signal masculine or feminine associations. This research examines the effects of such gender associations on three important brand outcomes: attitudes, choice, and performance. Across six studies using both observational analyses of real brands and experimental manipulations of invented brands the authors show that linguistically feminine names increase perceived warmth, which improves brand outcomes. Feminine brand names enhance attitudes and choice share–both hypothetically and consequentially–and are associated with better brand performance. The authors establish boundary conditions, showing that the feminine brand name advantage is attenuated when the typical user is male and when products are utilitarian.

scholarly journals Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US

2015 ◽  
Vol 16 (6) ◽  
pp. 207-218 ◽  
Author(s):  
Pamela P. Pei ◽  
Milton C. Weinstein ◽  
X. Cynthia Li ◽  
Michael D. Hughes ◽  
A. David Paltiel ◽  
...  
Keyword(s):  
Comparative Effectiveness ◽  
Value Of Information ◽  
Brand Name ◽  
The Us ◽  
Effectiveness Trials

Knowledge of Brand and Preference

1995 ◽  
Vol 76 (3_suppl) ◽  
pp. 1297-1298 ◽  
Author(s):  
Pamela Bonham ◽  
Dana Greenlee ◽  
Cherly Sue Herbert ◽  
Lidi Hruidi ◽  
Cheryl Kirby ◽  
...  
Keyword(s):  
Consumer Products ◽  
Brand Names ◽  
Brand Name ◽  
Lack Of Knowledge

In a test of whether knowledge of brand influenced 74 subjects' preferences for chocolate candy, knowledge of brand name was associated with preference for the brand. Lack of knowledge of the distinction between brand-name and generic candies was associated with no preference. Gender was not a factor. The results are discussed in terms of the role brand names play in the attractiveness of consumer products.

scholarly journals Land Use and Family Formation in the Settlement of the US Great Plains

2012 ◽  
Vol 36 (3) ◽  
pp. 279-310 ◽  
Author(s):  
Myron P. Gutmann ◽  
Sara M. Pullum-Piñón ◽  
Kristine Witkowski ◽  
Glenn D. Deane ◽  
Emily Merchant
Keyword(s):  
Land Use ◽  
Great Plains ◽  
Agricultural Land ◽  
Family Formation ◽  
Descriptive Analysis ◽  
The United States ◽  
Level Data ◽  
The Us ◽  
Intensive Cropping ◽  
Western Great Plains

In agricultural settings, environment shapes patterns of settlement and land use. Using the Great Plains of the United States during the period of its initial Euro-American settlement (1880–1940) as an analytic lens, this article explores whether the same environmental factors that determine settlement timing and land use—those that indicate suitability for crop-based agriculture—also shape initial family formation, resulting in fewer and smaller families in areas that are more conducive to livestock raising than to cropping. The connection between family size and agricultural land availability is now well known, but the role of the environment has not previously been explicitly tested. Descriptive analysis offers initial support for a distinctive pattern of family formation in the western Great Plains, where precipitation is too low to support intensive cropping. However, multivariate analysis using county-level data at 10-year intervals offers only partial support to the hypothesis that environmental characteristics produce these differences. Rather, this analysis has found that the region was also subject to the same long-term social and demographic changes sweeping the rest of the country during this period.

scholarly journals GAMBARAN KEJADIAN MEDICATION ERROR DI INSTALASI GAWAT DARURAT RSU ELIM RANTEPAO

PHARMACON ◽  
2019 ◽  
Vol 8 (1) ◽  
pp. 152
Author(s):  
Priskha Widiastuti ◽  
Gayatri Citraningtyas ◽  
Jainer P Siampa
Keyword(s):  
Data Collection ◽  
Medication Error ◽  
Medication Errors ◽  
Health Personnel ◽  
Dosage Form ◽  
Emergency Services ◽  
Descriptive Analysis ◽  
Medical Record Number ◽  
Prospective Data ◽  
Prescription Date

ABSTRACT Medication Error is an event that is detrimental to the patient due to errors in the administration of drugs during the handling of health personnel, which can actually be prevented. Data on incidents of medication errors at Elim Hospital, Rantepao in 2017 were 85 cases (0.085% of the total 98,892 prescription sheets served). This study aims to determine the incidence and the percentage of medication errors during the prescribing and dispensing phase in the Emergency Installation of Elim Hospital ,Rantepao. This research is a descriptive analysis with prospective data collection. The results showed that medication errors which occurred at prescribing stage included no prescription doctor's name was 9.19%, no medical record number was 6.13%, no doctor's initial was 99.61%, patient's name was not clear was 0.57% , there was no patient age, was 6.89%, no concentration / dosage was 2.68%, no dosage form was 52.10%, and no prescription date was  1.72%. While medication errors at the dispensing stage include taking the drug was 0.38% and the lack of drug prepared was 0.19%. Based on the results of the study, it can be concluded that the biggest occurrence of medication errors in Emergency Services at Elim Hospital, Rantepao was occurred in the prescribing phase.Keywords: medication error, prescribing, dispensing, Emergency Installation ABSTRAKMedication Error adalah kejadian yang merugikan pasien akibat kesalahan dalam pemberian obat selama penanganan tenaga kesehatan, yang sebetulnya dapat dicegah.  Data insiden kejadian medication error RSU Elim Rantepao pada tahun 2017 yaitu sebanyak 85 kasus (0,085 % dari total 98.892 lembar resep yang dilayani). Penelitian ini bertujuan menentukan kejadian dan persentase medication error pada fase prescribing dan dispensing di Instalasi Gawat Darurat RSU Elim Rantepao. Penelitian ini merupakan penelitian yang bersifat analisis deskriptif dengan pengumpulan data secara prospektif. Hasil penelitian menunjukkan bahwa medication error yang terjadi pada tahap prescribing meliputi tidak ada nama dokter penulis resep 9,19%, tidak ada nomor rekam medik 6,13%, tidak ada paraf dokter 99,61%, nama pasien tidak jelas 0,57%, tidak ada usia pasien 6,89%, tidak ada konsentrasi/dosis sediaan 2,68%, tidak ada bentuk sediaan 52,10 %, dan tidak ada tanggal pembuatan resep 1,72%. Sedangkan medication error pada tahap dispensing meliputi salah pengambilan obat 0,38% dan obat ada yang kurang 0,19%. Berdasarkan hasil penelitian maka dapat disimpulkan bahwa kejadian medication error di Instalasi Gawat Darurat RSU Elim Rantepao terbesar yaitu terjadi pada fase prescribing.Kata-kata kunci : medication error , prescribing, dispensing, Instalasi Gawat Darurat

Sign in / Sign up

Export Citation Format

Share Document